Back
Arch Resources Vs. Janux Therapeutics Industry Stock Comparison
Sell
47
ARCH
Arch Resources
Last Price:
164.32
Seasonality Move:
10.09%
Sell
34
JANX
Janux Therapeutics
Last Price:
66.94
Seasonality Move:
133.13%
Sell
47
Arch Resources (ARCH)
is a Sell
Is Arch Resources a Buy, Sell or Hold?
- The current Arch Resources [ARCH] share price is $168.26. The Score for ARCH is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- ARCH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $59.86. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARCH Stock Price Chart
What is Arch Resources's stock price today?
-
The Arch Resources share price today is $168.26
The current trend is moderately bearish and ARCH is experiencing slight selling pressure.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $59.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
ARCH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.02 | Buy |
Relative Strength Index (14 RSI): | 59.27 | Buy |
Chaikin Money Flow: | -66197 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (152.77 - 174.13) | Buy |
Bollinger Bands (100): | (126.99 - 158.67) | Buy |
JANX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 63.62 | Buy |
Chaikin Money Flow: | -6955717 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.07 - 55.53) | Buy |
Bollinger Bands (100): | (41.63 - 51.75) | Buy |
ARCH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 172.57 | Sell |
20-day SMA: | 168.11 | Buy |
50-day SMA: | 151.6 | Buy |
200-day SMA: | 152.88 | Buy |
8-day EMA: | 170.42 | Sell |
20-day EMA: | 166 | Buy |
50-day EMA: | 155.6 | Buy |
200-day EMA: | 150.51 | Buy |
JANX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.16 | Buy |
20-day SMA: | 50.4 | Buy |
50-day SMA: | 49.88 | Buy |
200-day SMA: | 44.87 | Buy |
8-day EMA: | 49.16 | Buy |
20-day EMA: | 49.72 | Buy |
50-day EMA: | 49.41 | Buy |
200-day EMA: | 41.75 | Buy |
Arch Resources Earnings Growth & ARCH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $22.03 per share, and an increase next year of $17.42 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.91 per share.
Arch Resources Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Janux Therapeutics Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |